Dr.ย Noa Efratย Ben-Baruch
MD, Oncology
Medical Oncologist & Breast Cancer Specialist
corporate_fareKaplan Medical Center, Rehovot, Israel
Noa Efrat Ben-Baruch
MD, Oncology
Dr. Noa Efrat Ben-Baruch is an Israeli medical oncologist based at the Oncology Institute of Kaplan Medical Center in Rehovot. Her clinical and academic work is centred on breast cancer, including metastatic breast cancer, HER2-positive and HER2-mutated disease, and hormone receptor-positive subtypes. She leads the breast oncology consultation clinic at the Kaplan Breast Health Center.
Dr. Ben-Baruch has contributed to peer-reviewed research on advanced and metastatic breast cancer, including studies on endocrine therapy resistance, chemotherapy sequencing in HR-positive/HER2-negative disease, targeted therapy with everolimus plus letrozole, and neratinib for HER2-mutated breast cancer. She has served as Head of the Department of Oncology at Kaplan Medical Center and as Head of the Israeli Breast Cancer Group, positions that reflect her standing in Israel's breast oncology community. Her published work spans clinical trial findings, genomic recurrence-score-guided treatment decisions, and registry-based real-world outcomes. International patients seeking an expert second opinion or advanced treatment planning in breast cancer may find her profile particularly relevant for complex receptor-specific and metastatic disease decisions.
CancerFax can coordinate medical-report review and consultation support for international patients seeking an opinion from Dr. Ben-Baruch at Kaplan Medical Center, subject to hospital availability and case acceptance.
Why Consider Dr. Noa Efrat Ben-Baruch?
Dr. Ben-Baruch combines clinical breast oncology expertise at Kaplan Medical Center with a strong research record and recognised leadership in Israeli breast cancer programmes.
Areas of Specialisation
Advanced breast oncology across all subtypes and disease stages
Dr. Ben-Baruch's clinical expertise spans the full spectrum of breast cancer management, with a particular focus on systemic treatment planning for advanced and metastatic breast cancer, receptor-specific strategies, and genomic-guided decision-making.
Metastatic & Advanced Breast Cancer
Systemic treatment planning for patients with advanced or metastatic breast cancer across all receptor subtypes.
- arrow_rightEndocrine therapy and CDK4/6 inhibitor combinations
- arrow_rightChemotherapy sequencing for endocrine-resistant disease
- arrow_rightEverolimus-based regimens for hormone receptor-positive advanced disease
- arrow_rightHER2-directed treatment planning including trastuzumab-based regimens
- arrow_rightNeratinib for HER2-mutated breast cancer (published clinical research)
- arrow_rightSystemic management of metastatic HER2-positive disease
Endocrine Therapy & Targeted Treatment
Evidence-based systemic therapy for hormone receptor-positive breast cancer, including endocrine combinations and resistance management.
- arrow_rightLetrozole and everolimus combinations in HR-positive/HER2-negative advanced disease
- arrow_rightManagement of endocrine therapy resistance
- arrow_rightBiomarker and receptor-status-guided treatment selection
- arrow_rightRecurrence-score testing to guide chemotherapy decisions in ER-positive breast cancer
- arrow_rightRegistry-based analysis of genomic outcomes in Israeli breast cancer populations
- arrow_rightIntegration of molecular profiling into clinical decision-making
Procedures & Clinical Services
Systemic treatment, second opinion, and multidisciplinary breast cancer care
Dr. Ben-Baruch's clinical services focus on medical oncology for breast cancer, encompassing systemic treatment planning, targeted therapy, endocrine management, and expert second opinion consultations.
Systemic Breast Cancer Treatment
Medical OncologyChemotherapy, endocrine therapy, and combination regimens tailored to receptor status, disease stage, and prior treatment history.
HER2-Directed & Targeted Therapy
Targeted TherapyMolecularly guided treatment strategies for HER2-positive and HER2-mutated breast cancer.
Diagnostic Review & Treatment Planning
DiagnosisComprehensive review of pathology, receptor status, molecular profiling, and imaging to guide treatment decisions.
Second Opinion Consultation
Second OpinionIndependent expert review for patients with breast cancer seeking a second perspective on diagnosis, receptor-specific therapy, or advanced disease management.
Research & Publications
Peer-reviewed contributions to breast cancer science and clinical practice
Dr. Ben-Baruch has contributed to PubMed-indexed research across metastatic breast cancer, HER2-directed therapy, endocrine treatment, genomic decision-making, and real-world registry outcomes.
Dr. Ben-Baruch's publications span clinical trial findings and registry analyses. A full publication list may be available on request through Kaplan Medical Center or PubMed.
Education & Training
Dr. Ben-Baruch holds an MD degree, verified through her publication and professional listings. Detailed medical school and training institution information is not publicly available.
Clinical Experience
Dr. Ben-Baruch is a medical oncologist affiliated with the Oncology Institute at Kaplan Medical Center in Rehovot, Israel. She has served as former Head of the Department of Oncology at Kaplan Medical Center and as Head of the Israeli Breast Cancer Group.
Languages & International
Dr. Ben-Baruch conducts consultations at Kaplan Medical Center. Language preferences are not publicly verified; CancerFax can coordinate interpreter support as required.
CancerFax can coordinate professional medical interpreter support for international patients consulting with Dr. Ben-Baruch.
CancerFax can coordinate professional medical interpreter support for international patients in Arabic, Russian, French, and other languages.
How CancerFax Helps You Access Dr. Noa Efrat Ben-Baruch
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Noa Efrat Ben-Baruch's team โ with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history โ prepared as a structured clinical summary for Dr. Noa Efrat Ben-Baruch's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Noa Efrat Ben-Baruch before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. Noa Efrat Ben-Baruch's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. Noa Efrat Ben-Baruch's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. Noa Efrat Ben-Baruch's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Dr. Noa Efrat Ben-Baruch
Dr. Ben-Baruch specialises in breast cancer, including metastatic breast cancer, HER2-positive and HER2-mutated breast cancer, hormone receptor-positive/HER2-negative breast cancer, triple-negative breast cancer, and male breast cancer. Her clinical and research focus covers the full range of breast cancer subtypes.
Dr. Ben-Baruch is affiliated with the Oncology Institute at Kaplan Medical Center in Rehovot, Israel, which is part of the Clalit Health Services network. She also leads an oncology consultation clinic at the Kaplan Breast Health Center.
CancerFax can coordinate medical-report review and consultation support for international patients seeking an opinion from Dr. Ben-Baruch at Kaplan Medical Center, subject to hospital availability and case acceptance. Please submit your reports through CancerFax for an initial review.
A second-opinion request can be submitted through CancerFax with the patient's pathology reports, imaging, receptor status results, genomic test reports, and treatment history. The final consultation format and availability depend on Dr. Ben-Baruch's schedule at Kaplan Medical Center.
Dr. Ben-Baruch's published research and clinical practice include chemotherapy, endocrine therapy, targeted therapy, HER2-directed treatment approaches, everolimus plus letrozole for endocrine-resistant advanced breast cancer, neratinib for HER2-mutated breast cancer, and genomic recurrence-score-guided treatment decision-making.
Submit your medical reports using the Send Your Reports button on this page. The CancerFax team will review your documents, prepare a structured case summary, and coordinate the next steps with Kaplan Medical Center on your behalf, subject to availability.
Connect with Noa Efrat Ben-Baruch Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.